Author: Customer Service

EINDHOVEN, the Netherlands, April 01, 2026 (GLOBE NEWSWIRE) — ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injuries (SCI) and other movement disabilities, today convened the 2026 Annual General Meeting of Shareholders (AGM), which will be held in Amsterdam, the Netherlands, on May 13, 2026. The resolutions proposed by the Board, to be submitted for adoption at the AGM, are as follows:Discussion of the annual report over the financial year 2025 (discussion item)  Adoption of the annual accounts over the financial year 2025 (voting item)           Implementation of the compensation policy over the financial year 2025 (advisory non-binding voting item)  Explanation of the dividend and reservation policy...

REGULATED RELEASE Availability of 2025 Universal Registration Document Paris – April 1, 2026 Klépierre has filed today the French version of its universal registration document relating to fiscal year 2025, prepared in ESEF format (European Single Electronic Format) with the Autorité des marchés financiers (“AMF”), under the registration number D.26-0185. It can be read or downloaded on the websites of:Klépierre: www.klepierre.com, in the section Finance/Publications/Annual and semi-annual reports; The AMF: www.amf-france.org.An English version of the universal registration document is also available online. The French version of the universal registration document as well as its English translation are also available to the public, free of charge upon request:By mail:KlépierreInvestor Relations26, boulevard des Capucines75009...

SHANGHAI, April 01, 2026 (GLOBE NEWSWIRE) — CHC Navigation (CHCNAV), a global provider of surveying, mapping, and positioning GNSS technology, announced major updates to its i93, i85, and i76 GNSS receivers, as well as the iBase professional base station. The updates are designed to further improve positioning stability, simplify field setup, and expand operational capability across demanding surveying environments. Enhanced RTK performance with the CHCNAV StellaX GNSS chipThe updated i93, i85, and i76 receivers integrate the CHCNAV StellaX GNSS chip with multi frequency signal tracking and advanced anti interference mitigation. This design is intended to support more reliable GNSS RTK positioning and more consistent data collection in complex terrain and in areas with partial GNSS satellite visibility. PointSky GNSS corrections...

The Ai.R (Autonomously Intelligent Ride) service is operated by Grab and features WeRide’s GXR and Robobus autonomous vehicle (AV) models.  The Ai.R fleet has successfully served more than 1,000 early riders and clocked over 30,000km of autonomous mileage. The development of the Ai.R service has unlocked new career paths for Grab’s driver-partners, including roles such as Safety Operator and Remote Operator. Interested members of the public can now register to experience the AV service (visit rideair.ai to reserve your ride).SINGAPORE, March 31, 2026 (GLOBE NEWSWIRE) — WeRide (NASDAQ: WRD, HKEX: 0800), a global leader in autonomous driving technology, and Grab (NASDAQ: GRAB), Southeast Asia’s leading superapp, today officially commenced public operations for the Ai.R (Autonomously Intelligent Ride) service in Punggol. Starting...

GUADALAJARA, Mexico, March 31, 2026 (GLOBE NEWSWIRE) — Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE: PAC; BMV: GAP) (the “Company” or “GAP”) announces that today it successfully completed the issuance in the Mexican market of 107.18 million long-term bond certificates (certificados bursátiles), for a total amount of Ps. 10,718.0 million. The issuance was carried out through two tranches and reached an oversubscription of 1.74x over the announced amount. The main characteristics of the transaction are as follows:“GAP 26”: Issuance of 27.67 million long-term debt securities with a three-year maturity, each with a nominal value of Ps. 100.0, for a total amount of Ps. 2,767.0 million. Interest will be payable every 28 days at a variable rate equal to TIIE funding rate plus 45 basis points. Principal payment is due at maturity,...

HOUSTON, March 31, 2026 (GLOBE NEWSWIRE) — FibroBiologics, Inc. (NASDAQ: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced the pricing of a best efforts public offering of an aggregate of 2,272,728 shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to 2,272,728 shares of common stock (the “Warrants”), at a combined public offering price of $1.32 per share (or per common stock equivalent in lieu thereof) and accompanying Warrant. The Warrants will have an exercise price of $1.32 per share and will be exercisable beginning on the effective date of stockholder...